Company Overview and News

 
A Retail IPO With Nothing To Fear From Amazon

2018-01-29 seekingalpha
Most of Hudson's profits flow to non-controlling interests due to the Airport Concessions Disadvantaged Business Enterprises program.
Upvote Downvote

 
How Mechanical Watches Survived After Quartz: A Concise History - Bloomberg

2018-01-04 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
J C Penney Co. Needs a Big Move — Like a Breakup?

2018-01-02 investorplace
It was the tale of a failing mall in western Pennsylvania and its last anchor, a J C Penney Company Inc (NYSE:JCP) store. The author profiled the woman at the jewelry counter, trying hard to deliver personal attention to Christmas shoppers to keep her job, and a former mall cop who now calls himself an assistant manager and is trying to get shops rented.
Upvote Downvote

 
Leisure Stocks' Q3 Earnings Slated on Nov 8: SEAS, CNK & ILG

2016-11-07 zacks
The earnings season is gradually coming to a close. We notice that the Consumer Discretionary sector has, so far, outpaced most other sectors in terms of top and bottom-line growth. Per our latest Earnings Preview report, 74.3% of the Consumer Discretionary companies in the S&P 500 index have reported their results, as of Nov 4. Growth rate for earnings and revenues is 15% and 17.1%, respectively. Moreover, the beat ratios for this sector have been remarkable (73.
Upvote Downvote

 
TAG Heuer Says Record Sales Possible Amid Industry Slump - Bloomberg

2016-11-06 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Leisure Stocks Earnings Releases on Nov 4: MSG, LIND, RDI

2016-11-03 zacks
We are well into the second half of the Q3 earning season and the widely diversified Consumer Discretionary sector has grabbed much of the attention. According to the latest Earnings Outlook, 54.3% of the Consumer Discretionary companies in the S&P 500 index have already reported their results as of Nov 2. The growth rate for earnings and revenues is 11% and 7.9%, respectively. Moreover, the beat ratios for this sector are noteworthy (68.
Upvote Downvote

 
LVMH-Moet Hennessy Louis Vuitton's (LVMHF) Management on Q3 2016 Results - Earnings Call Transcript

2016-10-11 seekingalpha
LVMH-Moet Hennessy Louis Vuitton (OTCPK:LVMHF) Q3 2016 Earnings Conference Call October 11, 2016 9:00 AM ET
Upvote Downvote

 
3 Broker Stocks to Watch as Rates Continue to Tick Higher

2016-10-04 zacks
Speculation over the timing of the next rate hike continues to influence the market sentiments. Several issues including the Brexit-induced uncertainties, U.S. dollar appreciation and the upcoming Presidential election might cause further delay in the hike. However, the positive domestic economic factors such as a recovery in job market and increased household spending certainly increase the odds of a hike by the end of this year.
Upvote Downvote

 
Fast beauty: Korean cosmetics shine in China, draw investors

2016-08-03 reuters
SEOUL, Aug 4 At an Innisfree cosmetics store in Seoul's popular Myeongdong shopping district, a saleswoman helps 21-year-old Chinese tourist Yang Hui carry her shopping baskets to the pay desk in front of a large display showing K-Pop star Yoona.
Upvote Downvote

 
Fast beauty: Korean cosmetics shine in China, draw investors

2016-08-03 channelnewsasia
SEOUL: At an Innisfree cosmetics store in Seoul's popular Myeongdong shopping district, a saleswoman helps 21-year-old Chinese tourist Yang Hui carry her shopping baskets to the pay desk in front of a large display showing K-Pop star Yoona.
Upvote Downvote

 
Louis Vuitton chief to lead LVMH's private equity business in Australia

2016-08-03 theage.com.au
Louis Vuitton Australia's chief executive has resigned to take on the job leading the company's private equity business L Catterton and focus of finding Australia's next big lifestyle brand.
Upvote Downvote

 
Louis Vuitton chief to lead LVMH's private equity business in Australia

2016-08-03 smh.com.au
Louis Vuitton Australia's chief executive has resigned to take on the job leading the company's private equity business L Catterton and focus of finding Australia's next big lifestyle brand.
Upvote Downvote

 
LVMH's (LVMHF) CEO Jean-Jacques Guiony on Q2 2016 Results - Earnings Call Transcript

2016-07-27 seekingalpha
LVMH-Moet Hennessy Louis Vuitton (OTCPK:LVMHF) Q2 2016 Results Earnings Conference Call July 26, 2016 12:00 PM ET
Upvote Downvote

 
Fendi celebrates 90 with show at Trevi

2016-07-07 ansa.it
(ANSA) - Rome, July 7 - Fendi will celebrate its 90th anniversary with a runway show Thursday at the Trevi Fountain IN Rome.     The brand, part of the LVMH Group, financed the fountain's restoration project with a contribution of 2.18 million euros.     Karl Lagerfeld and Silvia Venturini Fendi will preside over the anniversary event, which doubles as the inauguration for this year's Altaroma fashion week (of which Silvia Venturini Fendi is president) taking place July 8-11.
Upvote Downvote

 
LVMH-backed Asia private equity fund sued by fired executive

2016-06-21 livemint
Uday Mehra said that he had raised concerns over alleged behaviour at L Capital Asia Advisors, such as raising profit projections for an investment target to generate illegitimate gains in a separate fund
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...